New treatments for vulvar lichen sclerosus
Part of Women’s health & pregnancy clinical trials.
This trial compares three treatments for vulvar lichen sclerosus: a steroid ointment, a non-steroid ointment, and platelet-rich plasma therapy. It aims to see which works best for managing symptoms and improving skin health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 80 years old.
- You have been diagnosed with vulvar lichen sclerosus through a skin biopsy.
- You are willing to give written consent and follow study procedures.
- You have not had any prior treatment for vulvar lichen sclerosus.
- You do not have vulvar cancer or a condition that might affect the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a shot of concentrated healing cells from umbilical cord blood (called platelet-rich plasma) can help treat vulvar lichen sclerosus better than a placebo shot. It aims to find a new, safe option for women who are not helped by standard treatments.
This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.
This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.
This study compares two treatments—clobetasol steroid cream or a fractional CO2 laser—for women with vulvar lichen sclerosus who have not used steroid cream before. It looks at how inflammation changes after treatment.
This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.
This study tests whether a supplement called Collagendep can help reduce vulvar dryness in people with lichen sclerosus who are already receiving a fat grafting procedure. It aims to see if adding the supplement improves comfort and symptoms.
Hear when a new Vulvar Lichen Sclerosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.